Symbotic stock's rapid rise requires rapid growth -- but one analyst says it's not going to happen.Robotics stock Symbotic (SYM 21.25%) is on the fritz today, falling 21% through 1:40 p.m. ET, and you can blame Goldman Sachs for that.Because Goldman just downgraded Symbotic. Goldman downgrades SymboticIn a note out late last night, Goldman Sachs analyst Mark Delaney downgraded Symbotic stock to sell with a $47 price target."Market interest in automation and robotics related assets in general" has made Symbo ...

Market Overview - Major U.S. equities indexes experienced gains, with the Dow Jones Industrial Average rising by 0.3%, the S&P 500 increasing by 0.2%, and the Nasdaq climbing by 0.4% [1] Company Highlights - Boeing (BA) shares surged by 8% after the new CFO announced at a UBS conference that the company's production ramp-up plan is on schedule, following previous safety issues that had significantly slowed production last year. Boeing also expects to generate positive free cash flow next year after incurring substantial losses over the past two years [2] - Intel (INTC) stock rose by 7% as the company revealed plans to invest approximately $200 million to expand its manufacturing operations in Malaysia. This increase follows a rally initiated by reports suggesting that Apple (AAPL) could become a significant customer for Intel [3] - MongoDB (MDB) shares jumped nearly 25% after the company reported quarterly results that exceeded estimates and raised its full-year forecasts, following the appointment of a new CEO [3] - XPeng (XPEV), a Chinese electric vehicle manufacturer, saw its U.S.-listed shares decline by 6% after reporting November sales data. The company delivered just under 37,000 EVs, marking a 19% increase year-over-year, but falling short of October's sales figures amid intense competition in the Chinese EV market [4] - Symbotic (SYM) shares fell by 16% after a significant rally of nearly 40% following last week's earnings report. The company had exceeded sales estimates and announced its first partnership with a medical supply company [5] - Sandisk (SNDK), a recent addition to the S&P 500, led the decliners on the index with a 5% drop [5] Commodity and Currency Update - Crude oil futures decreased by 0.5% to approximately $59.00 per barrel, while gold futures fell by 1.4% to around $4,212 per ounce. The yield on the 10-year Treasury note remained stable at about 4.09% [6]

High vantage point view of an orderly warehouse. Key Points Symbotic is on track to expand its client base in 2026 and accelerate its growth outlook. Analysts are lifting price targets in December, underpinning a robust rebound and upside potential. Price action suggests this stock will reach $115 by early 2026 if not sooner. Interested in Symbotic Inc.? Here are five stocks we like better. Symbotic (NASDAQ: SYM) stock corrected by more than 30% in November, but the move was over before it began. T ...

Upgrades - Baird upgraded Albemarle (ALB) to Neutral from Underperform with a price target of $113, up from $81, due to optimism regarding lithium end-market demand tied to energy storage [2] - Morgan Stanley upgraded DexCom (DXCM) to Overweight from Equal Weight with a price target of $75, up from $63, citing signs of recovery from operational challenges while valuation remains at trough levels [2] - Argus upgraded Restaurant Brands (QSR) to Buy from Hold with an $85 price target, expecting strong brands to lead to higher domestic comparable sales and international unit expansion [3] - Truist upgraded Six Flags (FUN) to Buy from Hold with a price target of $23, down from $27, noting the new CEO's promising approach to improve underperforming parks [3] - Stifel upgraded Teradyne (TER) to Buy from Hold with a price target of $225, up from $162, anticipating accelerated growth due to a favorable shift in test revenue composition [4] Downgrades - Morgan Stanley downgraded Inspire Medical (INSP) to Equal Weight from Overweight with a price target of $130, up from $105, citing lack of visibility into the core business and long-term market potential [5] - Goldman Sachs downgraded Symbotic (SYM) to Sell from Neutral with an unchanged $47 price target, believing the valuation is stretched with a 185-times enterprise value to expected forward adjusted EBITDA multiple [5] - Oppenheimer downgraded Sound Point Meridian Capital (SPMC) to Perform from Outperform, removing the price target of $20, due to higher than expected negative impact on earnings from borrower call options [5] - Morgan Stanley downgraded 10x Genomics (TXG) to Equal Weight from Overweight with a price target of $20, up from $17, following a stock rally that placed the multiple in a reasonable spot relative to growth [5] - BofA downgraded PagerDuty (PD) to Underperform from No Rating with a $12 price target, citing demand headwinds and a pricing model change that may delay growth stabilization [5]

Mark Delaney from Goldman Sachs set a price target of $47 for SYM, which is approximately -44.9% from its current price.Symbotic's stock has risen by 4.04%, indicating investor optimism despite the significant price difference from the target.The company's market capitalization is approximately $51.51 billion, reflecting a strong market presence and active investor interest in the robotics technology sector.Symbotic Inc., trading on NASDAQ:SYM, is a company that focuses on automating warehouse operations th ...

Symbotic (SYM) is an automation technology leader that designs and deploys AI-powered robotic systems to modernize warehouse and supply chain operations. Its end-to-end platform uses intelligent software and high-speed autonomous robots to store, retrieve, and sequence goods with high efficiency, helping large retail, wholesale, and food & beverage companies improve speed, accuracy, and space utilization in distribution centers. Founded in 2007, Symbotic is headquartered in Wilmington, Massachusetts. Mor ...

Parkev Tatevosian, CFA has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Symbotic. The Motley Fool has a disclosure policy. Parkev Tatevosian is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through his link, he will earn some extra money that supports his channel. His opinions remain his own and are unaffected by The Motley Fool. ...

Market Overview - U.S. stocks closed higher on Friday, with the Nasdaq Composite gaining for the fifth consecutive session as hopes for rate cuts increased and risk appetite returned across technology, cryptocurrency, and commodities [1] - Despite the recent gains, the Nasdaq recorded a nearly 2% loss for November, while the S&P 500 and Dow experienced slight gains during the same month [1] Analyst Insights - Benzinga's Analyst Ratings API provides high-quality stock ratings through partnerships with major sell-side banks, offering daily updates on ratings changes three hours before the U.S. equity market opens [3] - Analyst insights from Benzinga Pro subscribers have been identified as effective trading indicators that can outperform the stock market [3] Top Analyst Picks - The latest stock picks from top analysts include: - John Todaro from Citigroup maintained a Neutral rating on HP Inc (NYSE:HPQ) with a price target cut from $27 to $25, indicating a potential upside of around 3% [5] - An analyst from Citizens maintained a Market Outperform rating on Zscaler Inc (NASDAQ:ZS) with a price target of $355, suggesting a potential upside of approximately 43% [5] - An analyst from Truist Securities maintained a Hold rating on Analog Devices Inc (NASDAQ:ADI) and raised the price target from $249 to $258, expecting a decline of around 3% [5] - An analyst from Baird maintained a Neutral rating on Symbotic Inc (NASDAQ:SYM) and increased the price target from $55 to $58, anticipating a decline of about 29% [5] - An analyst from Needham maintained a Buy rating on Robinhood Markets Inc (NASDAQ:HOOD) with a price target of $145, expecting a gain of around 16% [7]

Core Insights - There is significant hype surrounding artificial intelligence (AI), automation, and robotics, but the real-world applications are still being determined. Symbotic's growth and traction stand out in this speculative environment [1] - Following a strong Q4 fiscal 2025 earnings report and an optimistic Q1 2026 forecast, Symbotic's stock has seen a substantial rise. The focus is on whether Symbotic will set the standard in modern warehouse and supply chain transformation [2] Financial Performance - Symbotic's revenue for fiscal 2025 reached $2.247 billion, marking a 26% increase from the previous year [4] - The company reported significant increases in adjusted EBITDA, free cash flow, and adjusted gross profit margin in its Q4 earnings. It has a backlog of orders totaling approximately $22.5 billion [5][10] Clientele and Market Position - Symbotic has secured multi-year contracts with major companies such as Walmart, Target, and C&S Wholesale, indicating strong market demand for its systems [6] - The appeal of Symbotic's solutions is heightened by labor shortages and the need for cost reductions among major suppliers and retailers [7] Strategic Partnerships and Global Expansion - A partnership with SoftBank is facilitating Symbotic's entry into global markets, starting with Europe and Asia, which will test the company's execution capabilities [8] Research and Development - The company faces challenges related to high research and development costs, which are essential for maintaining a competitive edge. While overall expenses have increased, they have not outpaced revenue growth [11]

Core Insights - Symbotic's stock price surged 63.8% to an all-time high of $87.88 per share, driven by strong financial performance and new client acquisition [1][2] - The company reported a 26% increase in full-year revenue, reaching nearly $2.3 billion, and a 9% rise in fourth-quarter revenue [3] - Symbotic's operational robotic systems nearly doubled to 48, and it ended the fiscal year with a backlog of $22.5 billion, indicating robust growth potential [3][6] Financial Performance - Full-year revenue increased by 26% to nearly $2.3 billion, with fourth-quarter revenue up by 9% [3] - Gross margin stands at 18.07%, reflecting the company's profitability [5] Market Expansion - Symbotic is entering the healthcare market by signing Medline as a new customer, which is expected to unlock significant growth opportunities [6][7] - The partnership with Walmart, the largest customer, continues to strengthen, with Walmart financing new micro-fulfillment systems [5][6] Growth Potential - The entry into healthcare opens a massive new market for Symbotic, potentially attracting interest from other industries [7] - The company's substantial backlog of $22.5 billion is nearly ten times its revenue from the last fiscal year, indicating strong future demand [3][7]